脑部放疗，上午比下午敏感许多！2 j5 C& E! f3 x' Y0 q/ ]* A" D3 F
* P: o2 {/ n9 Q; S4 M H+ p3 b- C! K. t
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.8 q% }/ U/ I3 y! Z) \3 B
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
" F l) M/ m# S9 c) |. |8 G# aRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.; @# ]2 j* o5 }! H) k' v- X! _2 D
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.7 m8 t$ X( T+ ~+ M# @; y! U& b
, {/ ^; [4 B3 b) D
Abstract
8 [6 T. x0 ?5 }4 r$ gBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
; M9 B% Z% e7 G2 j& f
; G- Q$ m0 T) V3 iMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic." K; Q) w2 Z2 j6 C+ [+ {
3 T2 D# U' A" c5 ?6 q
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). h6 O' D' c. D! R1 \
2 F$ y# S$ C5 w. x
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.+ v3 d- C: G$ z* t4 a- {
) _$ E) c+ e" ]% d. }' G
|
11011102001537 )
+ z. }4 Q5 Z7 l& r, [6 F, J; D
显身卡
